openPR Logo
Press release

Rising Demand For Hormone Replacement Therapy Driving Market Growth: A Key Factor Shaping the Future of the Skytrofa Market in 2025

03-28-2025 08:47 AM CET | Health & Medicine

Press release from: The Business Research Company

Market ShareSkytrofa

Market ShareSkytrofa

How Are the key drivers contributing to the expansion of the skytrofa market?
The rising demand for hormone replacement therapy (HRT) is expected to propel the growth of the skytrofa market. Hormone replacement therapy (HRT) replaces hormones like estrogen and progesterone to alleviate menopause symptoms or hormonal imbalances. The increasing demand for HRT is driven by an aging population and growing recognition of its benefits in managing menopause symptoms. Skytrofa is used in HRT to treat growth hormone deficiency by stimulating growth and development through subcutaneous injections. For example, the National Health Service (NHS) in October 2023 reported that 11 million HRT prescriptions were given in England in 2022-2023, a 47% increase from 2021-2022. Additionally, approximately 2.3 million patients received HRT prescriptions, reflecting a 29% rise from the previous year. Therefore, the growing demand for HRT is boosting the skytrofa market.

Get Your Skytrofa Market Report Here:
https://www.thebusinessresearchcompany.com/report/skytrofa-global-market-report

What growth opportunities are expected to drive the skytrofa market's CAGR through 2034?
The Skytrofa market size has shown XX (HCAGR) in recent years. It will rise from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. The growth is driven by the increasing prevalence of growth deficiencies, the rise of online pharmacies, heightened concerns about passenger safety, increasing diagnoses, and rising blood sugar levels.

The Skytrofa market size is expected to see notable growth in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. Growth can be attributed to growing government initiatives, an increased elderly population, rising prevalence of growth hormone deficiency, increasing chronic disease prevalence, and a rising number of clinical trials. Trends include technological innovations in drug delivery systems, advancements in AI, drug delivery innovations, and a shift toward pediatric treatment innovation.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20357&type=smp

What are the emerging trends shaping the future of the skytrofa market?
The primary trend in the skytrofa market is centered around the development of innovative and inventive products like long-acting growth hormones. These products are designed to improve patient treatment adherence and convenience. Long-acting growth hormones, unlike daily injections, are formulations of the growth hormone that are typically administered on a less frequent, weekly or monthly basis, but still maintain their therapeutic effects. For example, in September 2023, Ascendis Pharma A/S, a biotechnology research firm based in Denmark, introduced SKYTROFA (lonapegsomatropin) in Germany, a treatment that is administered once a week for children and teenagers between the ages of 3 and 18 who suffer from growth hormone deficiency (GHD). This forward-thinking therapy simplifies the treatment procedure, offering a more user-friendly dosing schedule than daily growth hormone therapies. It employs pegylation technology to prolong the half-life of the medication, allowing it to deliver sustained effects over a week with just one injection. This development is intended to enhance patient adherence, diminish the hassle of regular injections, and ultimately, improve overall care quality for young patients.

Which growth-oriented segments of the skytrofa market are leading the industry's development?
The skytrofa market covered in this report is segmented -

1) By Indication: Growth Hormone Deficiency (GHD); Turner Syndrome; Idiopathic Short Stature (ISS); Prader-Willi Syndrome (PWS)
2) By Formulation: Liquid Formulation; Subcutaneous Injection
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Hospital; Clinicals; Ambulatory Care; Home Care

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20357

What regions are leading the charge in the skytrofa market?
North America was the largest region in the skytrofa market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skytrofa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the skytrofa market?
Major companies operating in the skytrofa market are Ascendis Pharma A/S

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20357&type=smp

What Is Covered In The Skytrofa Global Market Report?

•Market Size Forecast: Examine the skytrofa market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the skytrofa market for a structured understanding.
•Key Players Overview: Analyze major players in the skytrofa market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the skytrofa market.
•Segment Contributions: Evaluate how different segments drive overall growth in the skytrofa market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the skytrofa market.
•Industry Challenges: Identify potential risks and obstacles affecting the skytrofa market.
•Competitive Landscape: Review strategic developments in the skytrofa market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Demand For Hormone Replacement Therapy Driving Market Growth: A Key Factor Shaping the Future of the Skytrofa Market in 2025 here

News-ID: 3944067 • Views:

More Releases from The Business Research Company

Driving Plasma Rocket Propulsion Market Growth in 2025: The Role of Increasing Satellite Launches Fueling The Growth Of The Market Due To Rising Demand For Global Connectivity
Driving Plasma Rocket Propulsion Market Growth in 2025: The Role of Increasing S …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Plasma Rocket Propulsion Market Size Growth Forecast: What to Expect by 2025? The market size for plasma rocket propulsion has been experiencing significant growth in the past few years. The market size will increase from its 2024 value of $1.42 billion to reach $1.55 billion in 2025, reflecting a
Comprehensive Paver Blocks Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Comprehensive Paver Blocks Market Forecast 2025-2034: Growth Trends and Strategi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Paver Blocks Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the paver blocks market has experienced consistent growth in the past few years. It is projected to rise from $4.44 billion in 2024 to $4.65 billion in 2025, displaying a compound
Increasing Defense Budget Fueling The Growth Of The Market Due To Rising Investment In Advanced Space-Based Military Capabilities: Powering Innovation and Expansion in the Orbital Defense Systems Market by 2025
Increasing Defense Budget Fueling The Growth Of The Market Due To Rising Investm …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Orbital Defense Systems Market Through 2025? In recent times, the market size of the orbital defense system has seen a dramatic upswing. It's projected to escalate from $17.05 billion in 2024 to $18.33 billion in 2025, exhibiting a compound annual growth rate
2025-2034 Nuclear Missiles And Bombs Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Nuclear Missiles And Bombs Market Outlook: Key Drivers, Emerging Chall …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Nuclear Missiles And Bombs Industry Market Size Be by 2025? The market size for nuclear bombs and missiles has significantly expanded in the past few years. It's forecasted to rise from $8.89 billion in 2024 to $9.34 billion in 2025, reflecting a compound annual growth rate

All 5 Releases


More Releases for Skytrofa

Growth Hormone Deficiency Market Predicted to See Upsurge Through 2034, Highligh …
The Key Growth Hormone Deficiency Companies in the market include - Novo Nordisk, Ascendis Pharma, Double Point Ventures (Lumos Pharma), SCOHIA PHARMA, and others. The Growth Hormone Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Growth Hormone Deficiency market dynamics. DelveInsight's "Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2034 report offers
Global Growth Hormone Deficiency Market Analysis 2025-2030: Growth Drivers, Chal …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. How Big Is the Growth Hormone Deficiency Market Size Expected to Be by 2034? In recent times, the market size for growth hormone deficiency has experienced considerable growth. From $4.06 billion in 2024, its value is set to rise to $4.31 billion in 2025, showing a compound annual growth rate (CAGR) of
Evolving Market Trends In The Skytrofa Industry: Regulatory Approvals Driving In …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Expected Skytrofa Market Size During the Forecast Period? Over the past few years, the skytrofa market has seen a size expansion of XX (HCAGR). The anticipated growth from $XX million in 2024 to $XX million in 2025, will occur at a compound annual growth rate (CAGR) of XX%. The
Insulin-like Growth Factors Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Insulin-like Growth Factors Market"- By Type (Mechano Growth Factor, Somatomedin C, IGF 1), By End-user (Hospitals, Medical Centers), Industry Trends, and Global Forecasts, 2022-2035 And Segment Revenue and Forecast To 2031." The Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year
Global Growth Hormone Deficiency Market to Reach $5.42 Billion by 2029, Growing …
What market dynamics are playing a key role in accelerating the growth of the growth hormone deficiency market? The increasing prevalence of genetic disorders is projected to drive the growth of the growth hormone deficiency market. Genetic disorders are caused by mutations or abnormalities in an individual's DNA, either inherited or spontaneous. Factors such as advancements in diagnostic technology, greater awareness, rising maternal age, environmental influences, population growth, and improved survival
Skytrofa Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and G …
What Is the Estimated Market Size and Growth Rate for the Skytrofa Market? In recent years, the market size of Skytrofa has experienced a $XX (CAGR). The market is projected to expand from $XX million in 2024 to $XX million in 2025, exhibiting a compound annual growth rate (CAGR) of $XX%. The escalation during the historic period is primarily due to factors such as augmented growth deficiencies, the emergence of online